Homocystinuria due to methylene tetrahydrofolate reductase deficiency: A Patient Guide
At a Glance
Severe MTHFR deficiency is a rare inherited disorder that causes homocysteine to build up and methionine to fall. Early treatment with betaine, specialized folate, and B vitamins, plus regular metabolic monitoring, can reduce health risks but may not reverse established injury.
Homocystinuria due to severe MTHFR deficiency is a rare, inherited metabolic disorder that impairs the folate and sulfur-amino-acid pathways. It is a remethylation disorder, meaning the body lacks the functioning enzyme needed to recycle a substance called homocysteine back into an essential building block called methionine [1]. Because this recycling process is broken, homocysteine levels in the blood can rise to dangerously high levels while methionine levels often drop too low. This biochemical imbalance is the hallmark of the disease and serves as the primary target for all medical treatments [2].
It is vital to distinguish this rare condition from the common genetic variations, or polymorphisms, frequently discussed in online wellness communities. While many people carry minor variations in the MTHFR gene that may slightly influence how they process folate, severe MTHFR deficiency is an autosomal recessive disease [3]. This means a person has inherited pathogenic variants in both copies of the gene—one from each parent—resulting in an enzyme that has severely reduced or no activity. This is not a common variation; it is a serious medical condition that requires lifelong care from a metabolic specialist [4][5].
The condition generally presents in two ways, though the severity and age of onset can vary widely and are not perfectly predictable based solely on genetics. In the most severe infantile-onset cases, babies may show signs within weeks or months of birth, including feeding difficulties, seizures, or pauses in breathing [6]. In late-onset cases, symptoms may not emerge until childhood or even adulthood, often appearing as changes in walking, cognitive function, mood, or as unexplained blood clots [7]. While early treatment reduces risk, it cannot guarantee normal development or completely reverse established injury.
Living with severe MTHFR deficiency involves a highly individualized “treatment regimen” designed to bypass the impaired enzyme. The core of this treatment is betaine, a medication that provides an alternative path for the body to clear homocysteine [2]. Along with specialized forms of folate (like 5-MTHF or folinic acid) and other B-vitamins, this treatment works to restore chemical balance. Consistent treatment and close monitoring by a dedicated care team are the most powerful tools available to support long-term health and stability [5][8].
In this guide
6 chapters
Understanding Severe MTHFR Deficiency
Learn what severe MTHFR deficiency homocystinuria means, including symptoms, blood test patterns, betaine treatment, genetic testing, and specialist care.
Recognizing the Symptoms of MTHFR Deficiency
Learn the early and late symptoms of MTHFR deficiency, including seizures, movement changes, blood clots, emergency warning signs, and sick-day planning.
The Biology and Diagnosis of MTHFR Deficiency
Learn how MTHFR deficiency causes high homocysteine, why newborn screening can miss it, and how genetic testing and enzyme studies help confirm the diagnosis.
Managing Severe MTHFR Deficiency Through Treatment
Learn how severe MTHFR deficiency is treated with betaine, folate, B12, and methionine, plus blood-test monitoring for homocysteine and methionine levels.
Building Your Care Team and Ensuring Safety
Learn how to build a care team for severe MTHFR deficiency, avoid nitrous oxide, and plan surgery safely with an emergency letter and clot prevention steps.
Long-Term Management and Outlook
Learn how severe MTHFR deficiency affects long-term outlook, treatment goals, homocysteine monitoring, vascular health, and quality of life for patients.
Common questions in this guide
What is homocystinuria caused by severe MTHFR deficiency?
How is severe MTHFR deficiency inherited and confirmed?
What symptoms can severe MTHFR deficiency cause?
How is MTHFR deficiency homocystinuria treated?
What do homocysteine and methionine levels mean in this condition?
Can early treatment prevent long-term problems?
What should patients and families monitor day to day?
Get notified when new evidence is published on Homocystinuria due to methylene tetrahydrofolate reductase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Methylene Tetrahydrofolate Reductase Deficiency.
Kaur R, Correa ARE, Thakur S, et al.
Indian journal of pediatrics 2020; (87(11)):951-953 doi:10.1007/s12098-020-03290-3.
PMID: 32451826 - 2
First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.
Olivieri G, Bordugo A, Burnyte B, et al.
Journal of inherited metabolic disease 2026; (49(4)):e70177 doi:10.1002/jimd.70177.
PMID: 42231716 - 3
MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature.
Levin BL, Varga E
Journal of genetic counseling 2016; (25(5)):901-11 doi:10.1007/s10897-016-9956-7.
PMID: 27130656 - 4
Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.
Rommer PS, Zschocke J, Fowler B, et al.
Journal of the neurological sciences 2017; (383()):123-127 doi:10.1016/j.jns.2017.10.035.
PMID: 29246599 - 5
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.
Huemer M, Diodato D, Schwahn B, et al.
Journal of inherited metabolic disease 2017; (40(1)):21-48 doi:10.1007/s10545-016-9991-4.
PMID: 27905001 - 6
Influence of early identification and therapy on long-term outcomes in early-onset MTHFR deficiency.
Yverneau M, Leroux S, Imbard A, et al.
Journal of inherited metabolic disease 2022; (45(4)):848-861 doi:10.1002/jimd.12504.
PMID: 35460084 - 7
Clinical and molecular characterization of adult patients with late-onset MTHFR deficiency.
Marelli C, Lavigne C, Stepien KM, et al.
Journal of inherited metabolic disease 2021; (44(3)):777-786 doi:10.1002/jimd.12323.
PMID: 33089527 - 8
Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.
Huemer M, Mulder-Bleile R, Burda P, et al.
Journal of inherited metabolic disease 2016; (39(1)):115-24 doi:10.1007/s10545-015-9860-6.
PMID: 26025547
This page is for informational purposes only and does not constitute medical advice about severe MTHFR deficiency. Your metabolic specialist and care team should guide diagnosis, treatment, and monitoring.